Loss of Protocadherin‐12 L eads to D iencephalic‐ M esencephalic J unction D ysplasia S yndrome
Objective To identify causes of the autosomal‐recessive malformation, diencephalic‐mesencephalic junction dysplasia (DMJD) syndrome. Methods Eight families with DMJD were studied by whole‐exome or targeted sequencing, with detailed clinical and radiological characterization. Patient‐derived induced...
Saved in:
Published in | Annals of neurology Vol. 84; no. 5; pp. 638 - 647 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.11.2018
|
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
To identify causes of the autosomal‐recessive malformation, diencephalic‐mesencephalic junction dysplasia (DMJD) syndrome.
Methods
Eight families with DMJD were studied by whole‐exome or targeted sequencing, with detailed clinical and radiological characterization. Patient‐derived induced pluripotent stem cells were derived into neural precursor and endothelial cells to study gene expression.
Results
All patients showed biallelic mutations in the nonclustered
protocadherin‐12
(
PCDH12
) gene. The characteristic clinical presentation included progressive microcephaly, craniofacial dysmorphism, psychomotor disability, epilepsy, and axial hypotonia with variable appendicular spasticity. Brain imaging showed brainstem malformations and with frequent thinned corpus callosum with punctate brain calcifications, reflecting expression of
PCDH12
in neural and endothelial cells. These cells showed lack of
PCDH12
expression and impaired neurite outgrowth.
Interpretation
DMJD patients have biallelic mutations in
PCDH12
and lack of protein expression. These patients present with characteristic microcephaly and abnormalities of white matter tracts. Such pathogenic variants predict a poor outcome as a result of brainstem malformation and evidence of white matter tract defects, and should be added to the phenotypic spectrum associated with
PCDH12
‐related conditions. Ann Neurol 2018;84:638–647 |
---|---|
ISSN: | 0364-5134 1531-8249 |
DOI: | 10.1002/ana.25327 |